Reisemedizin up2date, Table of Contents Reisemedizin up2date 2025; 02(02): 94DOI: 10.1055/a-2557-3624 Update Impfungen Chikungunya: Totimpfstoff zugelassen, Empfehlung für Zulassungserweiterung von Lebendimpfstoff Sandra Witteck Recommend Article Abstract Buy Article Full Text References Literatur 1 European Medicines Agency (EMA). Vimkunya. Accessed March 27, 2025 at: https://www.ema.europa.eu/en/medicines/human/EPAR/vimkunya 2 European Medicines Agency (EMA). Ixchiq. Accessed March 05, 2025 at: https://www.ema.europa.eu/en/medicines/human/EPAR/ixchiq 3 European Commission. Union Register of medicinal products for human use. Vimkunya. Accessed March 05, 2025 at: https://ec.europa.eu/health/documents/community-register/2025/20250228165421/anx_165421_de.pdf 4 European Medicines Agency (EMA). Ixchiq – opinion on variation of marketing authorisation. Accessed March 05, 2025 at: https://www.ema.europa.eu/en/medicines/human/variation/ixchiq
